Gaudium IVF & Women's Health IPO Listing Sees Shares Debut at Premium Price, Subsequently Erodes Amid Market Volatility
Gaudium IVF and Women Health IPO Listing Review
Market Overview
On Friday, February 27, Gaudium IVF and Women Health shares made their debut on the BSE and NSE, opening at ₹83, a 5% premium to its issue price of ₹79. However, the stock failed to sustain gains due to weak market sentiment.
Listing Performance
Read also: SMR Jewels IPO Successfully Lists with Institutional Support
On the BSE, the stock opened at ₹83, erasing gains to hit a day's low of ₹79.05. On the NSE, the share price debuted at ₹83 and dropped to ₹80. At 10:30 am, the stock was trading at ₹80.75 on the BSE and ₹80.50 on the NSE.
Market Sentiment
The Indian stock market experienced strong selling in the morning session, with the Sensex declining by over 550 points and the Nifty 50 slipping below 25,300, falling 0.80%. This weak market sentiment negatively impacted the listing performance of Gaudium IVF and Women Health shares.
Investor Takeaway
Investors should be cautious of market volatility and potential stock price erosion after an initial premium listing.
More in IPO
SMR Jewels IPO Successfully Lists with Institutional Support
Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO
Merritronix IPO Sees Robust Subscription, Oversubscribed by 293 Times on Final Day
